| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Mendelson Daniel Newman serves as a Director at CSBR. Across recent SEC filings that breaks down to 32 buys and 2 sells. Those positions are worth an estimated $1.3M at current prices.
Historically, Mendelson Daniel Newman's trades have earned a middling insider score of 55/100 across 25 rated trades. Over a 12-month horizon, 44.0% of those trades were profitable, with an average 12-month return of +12.1%.
The biggest single holding is CSBR (~$1.3M) as Director. Net of sales, the recent Form 4 record there shows accumulation of 813,417 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 12, 2024 | CSBR Champions Oncology, Inc. | Director | Buy | 1,000 | $6.50 | $6,500.00 | +0.5% | -26.6% | +41.1% | |
| Jan 11, 2024 | CSBR Champions Oncology, Inc. | Director | Buy | 2,000 | $6.27 | $12,540.00 | +1.0% | -20.5% | +52.5% | |
| Jan 10, 2024 | CSBR Champions Oncology, Inc. | Director | Buy | 2,944 | $6.31 | $18,576.64 | +1.5% | -19.7% | +54.0% | |
| Jan 9, 2024 | CSBR Champions Oncology, Inc. | Director | Buy | 3,000 | $6.25 | $18,750.00 | +1.6% | -20.2% | +54.8% | |
| Jan 8, 2024 | CSBR Champions Oncology, Inc. | Director | Buy | 1,000 | $6.15 | $6,150.00 | +0.5% | -18.9% | +71.0% | |
| Jan 5, 2024 | CSBR Champions Oncology, Inc. | Director | Buy | 2,000 | $6.09 | $12,180.00 | +1.1% | -18.0% | +60.7% | |
| Jan 4, 2024 | CSBR Champions Oncology, Inc. | Director | Buy | 3,000 | $6.12 | $18,360.00 | +1.6% | -17.8% | +59.7% | |
| Jan 3, 2024 | CSBR Champions Oncology, Inc. | Director | Buy | 500 | $5.83 | $2,915.00 | +0.3% | -17.6% | +33.3% | |
| Dec 21, 2023 | CSBR Champions Oncology, Inc. | Director | Buy | 2,500 | $4.92 | $12,300.00 | +1.4% | +12.0% | +52.9% | |
| Dec 20, 2023 | CSBR Champions Oncology, Inc. | Director | Buy | 2,100 | $4.82 | $10,122.00 | +1.2% | +2.6% | +51.9% |